Lasukova T V, Uskina E V, Afanas'iev S A, Ponomarenko I V, Naryzhnaia N V, Cherniavskiĭ A M, Lishmanov Iu B
Tomsk Cardiology Institute, Research Center of Russian Academy of Medical Sciences, Russia.
Eksp Klin Farmakol. 1997 Sep-Oct;60(5):51-3.
Comparative study of the cardioprotective effect of antioxidants emoxipin and hystochrom was conducted in patients with chronic ICD during and after operation for aorto-coronary shunting. Both drugs effectively inhibited LPO activation and reduced the reperfusion damage to the myocardium recorded according to the release of MB-PCK into the blood. The new antioxidant hystochrom proved to be more effective. Its prevalent effect is associated with its higher antioxidant activity.
